$447 Million is the total value of SECTOR GAMMA AS's 37 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 22.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GILD | Buy | GILEAD SCIENCES INC | $52,132,000 | +28.7% | 843,427 | +23.8% | 11.66% | +32.5% |
MRK | Sell | MERCK & CO INC | $37,775,000 | -7.8% | 414,338 | -17.0% | 8.45% | -5.0% |
INCY | Buy | INCYTE CORP | $34,903,000 | -0.6% | 459,429 | +3.9% | 7.81% | +2.4% |
MDT | Buy | MEDTRONIC PLC | $26,074,000 | +14.1% | 290,521 | +41.0% | 5.83% | +17.5% |
BMY | Sell | BRISTOL-MYERS SQUIBB CO | $24,001,000 | -1.5% | 311,696 | -6.6% | 5.37% | +1.5% |
CAH | Buy | CARDINAL HEALTH INC | $20,176,000 | -5.7% | 385,988 | +2.3% | 4.51% | -2.9% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $19,855,000 | +13.4% | 532,735 | +34.8% | 4.44% | +16.7% |
BIIB | Buy | BIOGEN INC | $18,864,000 | +9.3% | 92,497 | +12.9% | 4.22% | +12.6% |
CI | Buy | CIGNA CORP NEW | $17,467,000 | +24.9% | 66,283 | +13.6% | 3.91% | +28.6% |
ANTM | Buy | ELEVANCE HEALTH INC | $16,552,000 | +16.1% | 34,300 | +18.2% | 3.70% | +19.6% |
BRKR | Sell | BRUKER CORP | $15,755,000 | -2.8% | 251,042 | -0.4% | 3.52% | +0.1% |
CVS | Sell | CVS HEALTH CORP | $15,577,000 | -22.6% | 168,111 | -15.5% | 3.48% | -20.3% |
CNC | Sell | CENTENE CORP DEL | $15,382,000 | -6.1% | 181,799 | -6.6% | 3.44% | -3.3% |
ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $14,262,000 | +72.1% | 135,749 | +109.5% | 3.19% | +77.2% |
NUVA | Sell | NUVASIVE INC | $12,167,000 | -19.3% | 247,502 | -7.0% | 2.72% | -17.0% |
OGN | Buy | ORGANON & CO | $12,018,000 | +1.3% | 356,089 | +4.8% | 2.69% | +4.3% |
QGEN | Sell | QIAGEN NV | $9,522,000 | -11.4% | 201,729 | -8.0% | 2.13% | -8.7% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $9,433,000 | +46.0% | 33,474 | +35.2% | 2.11% | +50.4% |
SGEN | New | SEAGEN INC | $8,988,000 | – | 50,795 | +100.0% | 2.01% | – |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,723,000 | +41.9% | 105,259 | +32.0% | 1.95% | +46.1% |
ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $6,249,000 | -35.4% | 42,844 | -27.7% | 1.40% | -33.5% |
IONS | Sell | IONIS PHARMACEUTICALS INC | $6,125,000 | -12.2% | 165,439 | -12.2% | 1.37% | -9.7% |
BIO | Sell | BIO RAD LABS INCcl a | $5,834,000 | -19.0% | 11,785 | -7.8% | 1.30% | -16.6% |
ABT | New | ABBOTT LABS | $5,346,000 | – | 49,205 | +100.0% | 1.20% | – |
PFE | Sell | PFIZER INC | $5,243,000 | -21.9% | 100,000 | -22.9% | 1.17% | -19.7% |
ITCI | INTRA-CELLULAR THERAPIES INC | $4,615,000 | -6.7% | 80,843 | 0.0% | 1.03% | -3.9% | |
SAGE | SAGE THERAPEUTICS INC | $3,827,000 | -2.4% | 118,476 | 0.0% | 0.86% | +0.5% | |
PTCT | Buy | PTC THERAPEUTICS INC | $3,400,000 | +14.1% | 84,864 | +6.3% | 0.76% | +17.4% |
NVAX | Buy | NOVAVAX INC | $2,845,000 | +0.8% | 55,324 | +44.4% | 0.64% | +3.9% |
VIR | Buy | VIR BIOTECHNOLOGY INC | $2,807,000 | +36.1% | 110,223 | +37.4% | 0.63% | +40.2% |
RARE | ULTRAGENYX PHARMACEUTICAL IN | $2,758,000 | -17.8% | 46,221 | 0.0% | 0.62% | -15.4% | |
UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $2,727,000 | -60.4% | 27,077 | -43.0% | 0.61% | -59.2% |
RIGL | RIGEL PHARMACEUTICALS INC | $1,657,000 | -62.2% | 1,466,678 | 0.0% | 0.37% | -61.1% | |
QTRX | QUANTERIX CORP | $1,436,000 | -44.5% | 88,670 | 0.0% | 0.32% | -42.9% | |
SOMALOGIC INC | $1,362,000 | -43.6% | 301,224 | 0.0% | 0.30% | -41.9% | ||
ATRA | ATARA BIOTHERAPEUTICS INC | $964,000 | -16.1% | 123,713 | 0.0% | 0.22% | -13.6% | |
New | EMBECTA CORP | $133,000 | – | 5,246 | +100.0% | 0.03% | – | |
MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -11,875 | -100.0% | -0.21% | – |
XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -55,516 | -100.0% | -0.59% | – |
PDCO | Exit | PATTERSON COS INC | $0 | – | -129,757 | -100.0% | -0.91% | – |
BDX | Exit | BECTON DICKINSON & CO | $0 | – | -26,233 | -100.0% | -1.52% | – |
AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -124,000 | -100.0% | -1.79% | – |
ELAN | Exit | ELANCO ANIMAL HEALTH INC | $0 | – | -364,691 | -100.0% | -2.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-05
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.